⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for metaiodobenzylguanidine (mibg)

Every month we try and update this database with for metaiodobenzylguanidine (mibg) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use ProtocolNCT01370330
Neuroblastoma
Metaiodobenzylg...
1 Year - University of California, San Francisco
High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed NeuroblastomaNCT01313936
Neuroblastoma
Metaiodobenzylg...
1 Year - 30 YearsUniversity of California, San Francisco
High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed NeuroblastomaNCT01313936
Neuroblastoma
Metaiodobenzylg...
1 Year - 30 YearsUniversity of California, San Francisco
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: